Resources
About Us
Home Report
Store
Bioreactors Market
Bioreactors Market Size, Share, Forecast, & Trends Analysis by Type (Continuous Stirred Tank, Photobioreactor), Bioprocess (Batch, Continuous), Usability (Reusable, Single-use), Scale (Pilot, Industrial), Cell Type, Application, User – Global Forecast to 2031
Report ID:MRHC - 1041133 Pages: 260 Jan-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Bioreactors Market was valued at $18.67 billion in 2023. This market is expected to reach $39.96 billion by 2031, from an estimated $20.38 billion in 2024, at a CAGR of 10.1% during the forecast period 2024-2031.
Bioreactors Market Size & Forecast
The growth of the bioreactors market can be attributed to several factors, including the capacity expansion of biopharmaceutical plants, the growing pharmaceutical market, rising pharmaceutical R&D expenditure, the rising adoption of biosimilars, and the growing adoption of single-use technologies in the pharmaceutical and biotechnology industries. Moreover, technological advancements in bioreactor technologies and the rising adoption of personalized medicines and cell & gene therapies are expected to offer growth opportunities for the players operating in this market.
Bioreactors Market Growth Drivers
-
Growing Adoption of Single-use Technologies
The state of the global economy, drug pricing control, and stricter quality & regulatory standards are forcing pharmaceutical companies to change their approaches. Companies are focusing more on process optimization and increasing operational efficiency to keep expenses down. This has resulted in the implementation of disposable or single-use technologies across laboratory-scale and commercial-scale operations. Pharmaceutical industries are using disposable technologies to minimize the risk of handling critical process operations, reduce contamination risks, and save time. The use of single-use bioreactor technologies has positively impacted the success rates of processes by reducing the risk of losses due to contamination.
Also, the capital expenditure on building single-use plants is usually 60-70% lower than that on building stainless steel plants, and the physical footprint is 30% smaller, further saving 90% in water costs and 50-60% in energy costs. Single-use technologies allowing for lower operational costs, smaller factories, and greener processing have encouraged major pharmaceutical manufacturers to adopt them gradually.
Click here to: Get a Free Sample Copy of this report
-
Capacity Expansion of Biopharmaceutical Manufacturing Plants
Several pharmaceutical companies are expanding their capacities to meet the growing demand for biopharmaceutical products. For instance
-
In September 2022, Eppendorf AG (Germany) expanded its bioprocess site in Jülich, Germany, to increase its bioprocess solutions production capacity by up to 20%.
- In September 2022, Merck KGaA (Germany) expanded its manufacturing capacity for the Mobius single-use portfolio by investing USD 137 million (EUR 130 million) in Molsheim, France.
- In June 2022, Merck KGaA (Germany) expanded the production of its Life Science business segment—Highly Potent Active Pharmaceutical Ingredients (HPAPI), with the expansion of its facility in Wisconsin, U.S., by investing USD 62 million (EUR 59 million).
-
Rising Adoption of Biosimilars Driving the Demand for Bioreactors
The global biopharmaceutical market revenue reached USD 275 billion. This revenue is expected to increase to USD 507 billion by 2023 at a CAGR of 12-14% due to the increasing number of bio-approvals, vendors’ focus on expanding biomanufacturing capacities, and government initiatives supporting bioproduction. In 2021, 5,500 new planned clinical trials have started, an increase of 14% over 2020 and 19% over 2019. The increasing focus on R&D is driving the adoption of biopharmaceutical equipment.
Government agencies around the globe are undertaking initiatives to support the growth of the biopharmaceutical market. For instance, the Chinese government has undertaken several initiatives for the development and commercialization of biosimilars. Countries like Malaysia, Indonesia, Thailand, and Taiwan have established regulatory pathways for biosimilars, increasing access to biosimilar technology. The production of biosimilars would increase the demand for bioreactors, therefore driving the growth of the market.
Bioreactors Market Trends
-
Rising Focus on Continuous Bioprocessing
Traditionally, the batch and fed-batch modes have dominated the manufacturing of pharmaceuticals. However, they have some limitations, such as the requirement for additional instruments for feedback control and being costlier compared to continuous bioprocessing. In continuous bioprocessing, the process is performed at a single location without interruption, as there is a continuous flow of raw materials in and out of the bioreactor. Moreover, continuous bioprocessing produces quality end products with no variations and offers steady-state operations, reduced equipment size, streamlined process flow, and lower capital costs.
Due to the growing demand for innovative and complex therapies and growing competition in the biopharmaceuticals market, biopharmaceutical manufacturers are reconsidering their manufacturing methods (shifting from batch to continuous manufacturing). Although batch manufacturing is the most preferred manufacturing method, continuous manufacturing is being increasingly accepted in the pharmaceutical industry due to its commercial advantages. These advantages have led to investments in the implementation of continuous bioprocessing systems.
-
Shift Towards Bioprocessing 4.0
Economic development in emerging economies, progressing research in biologics, and the increasing penetration of biopharmaceuticals have created tremendous opportunities for biopharmaceutical manufacturers, boosting the demand for biopharmaceutical processing equipment and consumables. The manufacture of biologics has grown over the last five years. The industry is shifting towards Bioprocessing 4.0 (a term derived from Industry 4.0), a national strategic initiative launched by the German government in 2010. Biomanufacturing 4.0 is still in its infancy. Bioprocessing 4.0 is defined as an end-to-end connected bioprocess, where all equipment and systems in the process are connected digitally through the Industrial Internet of Things (IIoT) to run, control, and enhance processes through feedback loops, machine learning, and artificial intelligence (AI). Thus, the expanding biopharmaceuticals landscape, coupled with manufacturers’ growing interest in Bioprocessing 4.0, is creating opportunities for market growth.
Bioreactors Market Opportunity
-
Technological Advancements in Bioreactor Technologies
Recent times have witnessed remarkable developments and advancements in bioreactor technologies and the components used for their construction. For instance, single-use bioreactors, made from different disposable materials, are cost-effective and reduce the risk of contamination. They also eliminate the need for cleaning and sterilization between batches, therefore streamlining the entire process.
Apart from this, microbioreactors are also gaining attention by using small amounts of resources. Microbioreactors are the miniaturized versions of 3D bioreactor systems that are majorly used for stem cell research. For instance, in May 2021, Beckam Coulter, Inc. (U.S.) launched the BioLector XT Microbioreactor system that enables high-throughput strain screening, cultivation parameter monitoring, and feeding strategy optimization. The integration of new technologies and systems enhances the efficiency, scalability, and productivity of the bioprocessing technique, contributing to the development of biotherapeutics, biosimilars, and other bioproducts, therefore increasing the demand for bioreactors.
Bioreactors Market Analysis: Key Findings
By Product: In 2024, the Continuous Stirred-tank Bioreactors Segment to Dominate the Bioreactors Market
Based on products, the market is segmented into continuous stirred-tank bioreactors, airlift bioreactors, fluidized-bed bioreactors, packed bed bioreactors, photobioreactors, and membrane bioreactors. In 2024, the continuous stirred-tank bioreactors segment is expected to account for the largest share of 31% of the bioreactors market. CSTR are reaction vessels in which reactants, reagents, and vessels flow in the reactor, and simultaneously output of the reaction exits the vessel. The large share of the segment is attributed to the unique ability of the vessel to handle higher reactant concentrations and more energetic reactions owing to their superior heat transfer properties in comparison to other bioreactors. Technological developments in CSTR also positively impact the market. The recent technological developments in CSTR pertain to the designs of bioreactors. Certain CSTR systems are designed to work alongside the other existing flow systems. For instance, in October 2023, Vapourtec Ltd. (U.K.) launched a CSTR that is designed for continuous process synthesis and works alongside the existing flow-chemistry systems.
By Bioprocess: In 2024, the Batch/Fed-batch Segment to Dominate the Bioreactors Market
Based on bioprocesses, the market is segmented into batch/fed-batch processing and continuous bioprocessing. In 2024, the batch/fed-batch segment is expected to account for the largest share of 62% of the bioreactors market. The batch/fed-batch or continuous bioprocessing is differentiated based on the feeding culture vessel. The preference for batch/fed-batch bioprocessing is higher, owing to fewer chances of contamination. The larger share of the segment is attributed to the benefits offered by batch/fed-batch bioprocessing, such as high productivity and ease in managing the bioprocesses. The duration of the batch processing is suitable for rapid experiments and speeds up the overall upstream processes, offering more productivity. Similarly, since there is no addition of nutrients or reactants in the middle of the procedure, the risk of cross-contamination is reduced and, therefore provides better traceability and control over quality.
However, the continuous bioprocessing segment is expected to register the highest CAGR of 12.40% during the forecast period of 2024–2031. Continuous bioprocessing is a process where raw materials/nutrients/reactants are continuously loaded or added to the bioreactor system. Cells are being continuously extracted and purified in a single connected system. This technique eliminates the downtime between two batches and increases the efficiency of resources and equipment. For instance, in November 2020, Merck KGaA (Germany) and Transcenta Holding (China) collaborated to implement continuous manufacturing for protein therapeutics. This collaboration brings the supplier and customer teams together to converge single-use, continuous, and digital bioprocessing technologies for further development of Trancenta’s integrated continuous bioprocessing (ICB) platform.
By Cell Type: In 2024, the Mammalian Cells Segment to Dominate the Bioreactors Market
Based on cell types, the market is segmented into mammalian cells, bacterial cells, yeast cells, and other cell types. In 2024, the mammalian cells segment is expected to account for the largest share of the bioreactors market. Mammalian cells are used as a culture for research, clinical, and pharmaceutical applications. These cells are isolated from animal tissues and can be expanded in culture to study cell biology and disease. It is also used to produce biomolecules such as antibodies, proteins, and vaccines. The large share of the segment is attributed to factors such as the growing focus on commercial and research bioproduction, such as developing complex biomolecules, including monoclonal antibodies and therapeutic proteins and the rise in clinical research of mammalian cells, and accordingly employing them in single-use bioreactors.
By Usability: The Reusable Bioreactors Segment to Dominate the Bioreactors Market
Based on usability, the market is segmented into reusable bioreactors and single-use bioreactors. In 2024, the reusable bioreactors segment is expected to account for the larger share of 79% of the bioreactors market. The large share of the segment is attributed to factors such as higher demand for large-scale manufacturing, obtainability of maximum flow rates, and better capital/operating cost considerations. Furthermore, the high cost and restrictions of waste disposal support the largest share of reusable bioreactors.
However, the single-use bioreactors segment is expected to grow at the fastest CAGR of 11.40% during the forecast period. Single-use bioreactors are sustainable systems with disposable vessels that are pre-assembled and pre-sterilized with all accessories. In recent times, there has been a rapid shift from stainless steel bioreactors to single-use bioreactors, typically made from polymers or plastic. According to the American Pharmaceutical Review, single-use systems are more widely adopted in pharmaceutical manufacturing, with nearly 85% of bioprocessing using disposables, therefore driving the demand for single-use bioreactors.
By Scale: The Pilot Scale Bioreactors (10L-200L) Segment to Witness Highest Demand During the Forecast Period
Based on scales, the market is segmented into lab scale bioreactors (0.5L-10L), pilot scale bioreactors (10L-200L), and Industrial scale bioreactors. In 2024, the pilot scale bioreactors (10L-200L) segment is slated to register the highest CAGR in the market. Pilot scale bioreactors are systems that are between the capacity of 10L-200L and include multiple variations and customizations. These types of bioreactors are mostly used in the food, pharmaceutical, and cosmetics industries. The pilot scale bioreactors are used for testing and optimizing bioprocesses before the full-scale production. Growing demand for commercial bioproduction drives the applications for pilot scale bioprocessing as pilot scale bioreactors determine efficiency, scalability, and performance close to industrial settings. Pilot scale rectors are used to analyze the risk and reduce the cost for industrial production, owing to which its demand in bioprocessing is growing rapidly.
By Automation: The Automated Bioreactors Segment to Dominate the Bioreactors Market
Based on automation, the market is segmented into manual/semi-automated bioreactors and automated bioreactors. In 2024, the automated bioreactors segment is expected to account for the larger share of the market. The large share of the segment is attributed to factors such as enhanced process quality, decreased errors, optimized process control, and cost savings in biopharmaceutical processing. Automated bioreactors improve quality and productivity, provide real-time monitoring, improve performance, and data-rich quality control. Automation streamlines the procedures or experiments and ensures prompt detection of deviations in the steps. The market players are launching technologically advanced automated bioreactors. For instance, in October 2022, Froilabo (U.K.) (a part of Techcomp Europe Ltd) launched fully automated lab-scale bioreactors that can be used for several applications such as academics, research, process development and optimization, scale-up, and production. These bioreactors have a novel magnetic mixer and non-welded lid that is ideal for bioprocesses that require high-grade aseptic conditions.
By Application: The Commercial Production Segment to Dominate the Bioreactors Market
Based on applications, the market is segmented into commercial production and developmental, preclinical & clinical. In 2024, the commercial production segment is expected to account for the larger share of 70% of the bioreactors market. The commercial production consists of monoclonal antibodies (mAb) production, cell & gene therapy production, vaccine manufacturing, plasma fractionation, and recombinant protein production. The large share is attributed to factors such as the growing adoption of biopharmaceuticals, regulatory reforms favoring the adoption of biosimilars, and growing investments and supportive initiatives in developing gene therapies. For instance, in April 2024, the President of India launched India’s first home-grown gene therapy for cancer at the Indian Institute of Technology, Bombay (India). This treatment, known as CAR-T cell therapy, has been developed through an academic-industry collaboration of the Indian Institute of Technology (IIT), Bombay, Tata Memorial Hospital (TMH), and ImmunoACT (India).
By End User: The Biopharmaceutical Manufacturers Segment to Dominate the Bioreactors Market
Based on end users, the market is segmented into biopharmaceutical manufacturers, research & development organizations, and contract manufacturing organizations. In 2024, the biopharmaceutical manufacturers segment is expected to account for the largest share of the market. Biopharmaceutical companies have witnessed significant growth in recent years due to the increasing demand for biopharmaceuticals, growing incidence of chronic diseases, rising R&D expenditure by pharmaceutical & biotechnology companies, and recent launches of biologics for chronic & rare diseases. Governments of various countries are taking initiatives by making investments and providing grants & funds to biopharmaceutical companies for the manufacture and R&D of biopharmaceuticals, along with several companies that are collaborating to develop sustainable methods for biomanufacturing.
Geographical Analysis
In 2024, North America is expected to account for the largest share of 34% of the bioreactors market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The largest share of the segment is primarily due to the presence of leading manufacturers, large R&D investments, support from government and regulatory authorities to promote the use of biopharmaceuticals, the presence of large biopharmaceutical companies, and expansion of manufacturing capacity by biopharmaceutical companies. For instance, in 2022, the U.S. accounted for about 45% of the global pharmaceutical market and 22% of global production. As per the International Trade Administration (ITA), the U.S. is the biggest biopharmaceutical market, comprising about a third of the global market, and is the dominant country in biopharmaceutical manufacturing and R&D.
The rise in the need for therapies for orphan and rare diseases is expected to encourage drug manufacturers to set up advanced processing facilities to help them produce medicines and generate maximum output. This also drives the demand for bioreactors in the region.
However, Asia-Pacific is slated to register the highest CAGR of 11.90% during the forecast period. This is attributed to factors such as the rising number of pharmaceutical and biopharmaceutical companies, growing patient population, increasing disposable income, and rising foreign direct investments (FDI) for pharmaceuticals and biopharmaceutical companies. For instance, the number of biopharmaceutical companies is growing steadily in China. As per data released by the Chinese president at the World Health Assembly 2020, between 2010–2020, over 140 new biotech companies have emerged in China, reaching over 500 biopharmaceutical companies active in the country. To further increase the presence of biopharmaceutical players in China, the government is emphasizing on increasing the production capacities of biopharmaceuticals in the country.
Bioreactors Market: Key Companies
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted in the last 3–4 years. Some of the key bioreactor manufacturers operating in the bioreactors market are Thermo Fisher Scientific, Inc. (U.S.), METTLER TOLEDO (U.S.), Merck KGaA (Germany), Eppendorf AG (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Donaldson Company, Inc. (U.S.), BBI-Biotech GmbH (Germany), Infors AG (Switzerland), and Pharsol Ltd. (Slovenia).
Bioreactors Industry Overview: Latest Developments from Key Industry Players
-
In November 2023, The Cultivated B GmbH (Germany) announced the launch of a bioreactor control software for its AUXO bioreactors that enables a real-time, application-based, personalized user interface with added remote accessibility.
-
In September 2023, Getinge AB (Sweden) launched the AppliFlex ST GMP single-use bioreactor system that is designed to bridge the gap between research and clinical production in cell and gene therapy and mRNA production.
- In April 2023, Cytiva (a subsidiary of Danaher Corporation) launched the X-platform bioreactors that simplify single-use upstream bioprocessing operations and are available in 50L and 200L sizes to improve efficiency through ergonomic improvements.
- In December 2022, Merck KGaA (Germany) acquired Erbi Biosystems, Inc. (U.S.) to strengthen its upstream portfolio by including 2 ml micro-bioreactor platform technology, Breez. This will allow Merck to offer a full range of bioreactors, from 2 ml to 2000L, advancing life-enhancing therapeutics.
Bioreactors Market Research Summary:
|
Particulars |
Details |
|
Number of Pages |
260 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2023 |
|
CAGR (Value) |
10.1% |
|
Market Size (Value) |
USD 39.96 Billion by 2031 |
|
Segments Covered |
By Product
By Bioprocess
By Cell Type
By Usability
By Scale
By Automation
By Application
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Ireland, Denmark, Belgium, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa |
|
Bioreactor Companies |
Thermo Fisher Scientific, Inc. (U.S.), METTLER TOLEDO (U.S.), Merck KGaA (Germany), Eppendorf AG (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Donaldson Company, Inc. (U.S.), BBI-Biotech GmbH (Germany), Infors AG (Switzerland), Pharsol Ltd. (Slovenia) |
Key questions answered in the bioreactors market report:
This market study covers the market sizes & forecasts of the bioreactors based on product, bioprocess, cell type, usability, scale, automation, application, end user, and geography. It also provides the value analysis of various segments and sub-segments of the global bioreactors market at country levels.
The bioreactors market is projected to reach $39.96 billion by 2031, at a CAGR of 10.1% during the forecast period.
The continuous stirred tank bioreactors segment is expected to account for the largest share of the market in 2024. Factors such as the ability of massive volume generation, easy temperature control, efficient mixing of reagents, uniform performance under steady-state conditions, and less expensive and easy construction of the system as compared to other dedicated flow systems are supporting the largest share.
Among scales, in 2024, the pilot scale bioreactors (10L-200L) segment is slated to register the highest CAGR in the market. Pilot scale bioreactors are systems that are between the capacity of 10L-200L and include multiple variations and customizations. The high CAGR is attributed to the growing demand for commercial biopharmaceuticals such as mAb and cell & gene therapies.
The growth of the bioreactors market is driven by several factors, including the capacity expansion of biopharmaceutical plants, the growing pharmaceutical market, rising pharmaceutical R&D expenditures, rising adoption of biosimilars, and growing adoption of disposable technologies in the pharmaceutical and biotechnology industries. Factors such as technological advancements in bioreactor technologies and rising adoption of personalized medicines and cell & gene therapies serve as major opportunities for the existing market players and new entrants in the bioreactors market.
The key players profiled in the bioreactors market report are Thermo Fisher Scientific, Inc. (U.S.), METTLER TOLEDO (U.S.), Merck KGaA (Germany), Eppendorf AG (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Donaldson Company, Inc. (U.S.), BBI-Biotech GmbH (Germany), Infors AG (Switzerland), Pharsol Ltd. (Slovenia).
In 2024, countries like China, Brazil, and India are expected to offer significant growth opportunities for the vendors in this market during the analysis period. This is due to factors such as the rising number of pharmaceutical and biopharmaceutical companies, growing patient population, increasing disposable income, rising foreign direct investments (FDI) for pharmaceuticals and biopharmaceutical companies, rise in demand for services and medicines in areas of orphan and rare diseases, and support from government and regulatory authorities to promote the use of biopharmaceuticals.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Capacity Expansion of Biopharmaceutical Plants
4.2.2. Growing Pharmaceutical Market
4.2.3. Rising Pharmaceutical R&D Expenditures
4.2.4. Rising Adoption of Biosimilars
4.2.5. Growing Adoption of Disposable Technologies in the Pharmaceutical and Biotechnology Industries
4.3. Restraints
4.3.1. Complex Development and Manufacturing Process of Biopharmaceuticals
4.3.2. Intensive Capital Requirements for Biopharmaceuticals Production
4.4. Opportunities
4.4.1. Technological Advancements in Bioreactor Technologies
4.4.2. Rising Adoption of Personalized Medicines and Cell & Gene Therapies
4.5. Challenges
4.5.1. Risk of Extractables and Leachables (E&L) in Biomanufacturing Processes Using Single-use Bioreactors
4.5.2. Process Scale-up Limitations
4.5.3. Need to Standardize Single-use Bioreactor Designs
4.5.4. Environmental Concerns Related to the Disposal of Single-use Bioreactors
4.6. Technology Trends/Market Trends
4.6.1. Use of Disposable Processing Equipment for Commercial Production
4.6.2. Rising Focus on Continuous Bioprocessing
4.6.3. Shift Towards Bioprocessing 4.0
4.6.4. Integration of AI in Bioprocessing
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Parent Market Analysis
4.10 Porter’s Five Forces Analysis
5. Global Bioreactors Market—by Type
5.1. Overview
5.2. Continuous Stirred-tank Bioreactors
5.3. Airlift Bioreactors
5.4. Fluidized-bed Bioreactors
5.5. Packed-bed Bioreactors
5.6. Photobioreactors
5.6.1. Open System Bioreactors
5.6.2. Closed System Bioreactors
5.7. Membrane Bioreactors
6. Global Bioreactors Market—by Bioprocess
6.1. Overview
6.2. Batch/Fed-batch Bioprocessing
6.3. Continuous Bioprocessing
7. Global Bioreactors Market—by Cell Type
7.1. Overview
7.2. Mammalian Cells
7.3. Bacterial Cells
7.4. Yeast Cells
7.5. Other Cell Types
8. Global Bioreactors Market—by Usability
8.1. Overview
8.2. Reusable Bioreactors
8.2.1. Stainless Steel
8.2.2. Glass
8.3. Single-use Bioreactors
9. Global Bioreactors Market—by Scale
9.1. Overview
9.2. Lab Scale Bioreactors (0.5L-10L)
9.3. Pilot Scale Bioreactors (10L-200L)
9.4. Industrial Scale Bioreactors
9.4.1. 200L-500L
9.4.2. 500L-1000L
9.4.3. Above 1,500L
10. Global Bioreactors Market—by Application
10.1. Overview
10.2. Commercial Production
10.2.1. Monoclonal Antibodies (mAb) Production
10.2.2. Cell & Gene Therapy Production
10.2.3. Vaccine Manufacturing
10.2.4. Plasma Fractionation
10.2.5. Recombinant Protein Production
10.3. Development, Preclinical, & Clinical
11. Global Bioreactors Market—by End User
11.1. Overview
11.2. Biopharmaceutical Manufacturers
11.3. Research & Development Organizations
11.4. Contract Manufacturing Organizations
12. Bioreactors Market—by Geography
12.1. Overview
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.3. Europe
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Switzerland
12.3.7. Ireland
12.3.8. Denmark
12.3.9. Belgium
12.3.10. Rest of Europe
12.4. Asia-Pacific
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. South Korea
12.4.5. Rest of Asia Pacific
12.5. Latin America
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Middle East & Africa
13. Competition Analysis
13.1. Overview
13.2. Key Growth Strategies
13.3. Competitive Benchmarking
13.4. Competitive Dashboard
13.4.1. Market Leaders
13.4.2. Market Differentiators
13.4.3. Vanguards
13.4.4. Emerging Companies
13.5. Market Share Analysis (2023)
14. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
14.1. Thermo Fisher Scientific, Inc.
14.2. METTLER TOLEDO
14.3. Merck KGaA
14.4. Eppendorf AG
14.5. Sartorius AG
14.6. Danaher Corporation
14.7. Donaldson Company, Inc.
14.8. BBI-Biotech GmbH
14.9. Infors AG
14.10. Pharsol Ltd.
14.11. Other Companies
(Note: SWOT analysis of the top 5 companies will be provided.)
15. Appendix
15.1. Available Customization
15.2. Related Reports
List of Tables
Table 1 Global Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 2 Global Continuous Stirred-tank Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Airlift Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Fluidized-bed Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Packed-bed Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 7 Global Photobioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Open System Photobioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Closed System Photobioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Membrane Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 12 Global Batch/Fed-batch Bioprocessing Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Continuous Bioprocessing Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 15 Global Bioreactors Market for Mammalian Cells, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Bioreactors Market for Bacterial Cells, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Bioreactors Market for Yeast Cells, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Bioreactors Market for Other Cells, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 20 Global Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 21 Global Reusable Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Stainless Steel based Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Glass-based Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Single-use Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 26 Global Lab Scale Bioreactors (0.5L-10L) Market, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Pilot Scale Bioreactors (10L-200L) Market, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 29 Global Industrial Scale Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 30 Global 200L-500L Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 31 Global 500L-1000L Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Above 1,500L Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 33 Global Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 34 Global Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 35 Global Monoclonal Antibodies (mAb) Production Market, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Cell & Gene Therapy Production Market, by Country/Region, 2022–2031 (USD Million)
Table 37 Global Vaccine Manufacturing Market, by Country/Region, 2022–2031 (USD Million)
Table 38 Global Plasma Fractionation Market, by Country/Region, 2022–2031 (USD Million)
Table 39 Global Recombinant Protein Production Market, by Country/Region, 2022–2031 (USD Million)
Table 40 Global Bioreactors Market for Developmental, Preclinical & Clinical Applications, by Country/Region, 2022–2031 (USD Million)
Table 41 Global Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 42 Global Bioreactors Market for Biopharmaceutical Manufacturers, by Country/Region, 2022–2031 (USD Million)
Table 43 Global Bioreactors Market for Research & Development Organizations, by Country/Region, 2022–2031 (USD Million)
Table 44 Global Bioreactors Market for Contract Manufacturing Organizations, by Country/Region, 2022–2031 (USD Million)
Table 45 Global Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 46 North America: Bioreactors Market, by Country, 2022–2031 (USD Million)
Table 47 North America: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 48 North America: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 49 North America: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 50 North America: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 51 North America: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 52 North America: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 53 North America: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 54 North America: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 55 North America: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 56 North America: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 57 North America: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 58 U.S.: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 59 U.S.: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 60 U.S.: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 61 U.S.: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 62 U.S.: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 63 U.S.: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 64 U.S.: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 65 U.S.: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 66 U.S.: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 67 U.S.: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 68 U.S.: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 69 Canada: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 70 Canada: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 71 Canada: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 72 Canada: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 73 Canada: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 74 Canada: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 75 Canada: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 76 Canada: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 77 Canada: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 78 Canada: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 79 Canada: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 80 Europe: Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 81 Europe: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 82 Europe: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 83 Europe: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 84 Europe: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 85 Europe: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 86 Europe: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 87 Europe: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 88 Europe: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 89 Europe: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 90 Europe: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 91 Europe: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 92 Germany: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 93 Germany: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 94 Germany: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 95 Germany: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 96 Germany: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 97 Germany: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 98 Germany: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 99 Germany: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 100 Germany: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 101 Germany: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 102 Germany: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 103 France: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 104 France: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 105 France: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 106 France: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 107 France: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 108 France: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 109 France: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 110 France: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 111 France: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 112 France: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 113 France: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 114 U.K.: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 115 U.K.: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 116 U.K.: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 117 U.K.: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 118 U.K.: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 119 U.K.: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 120 U.K.: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 121 U.K.: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 122 U.K.: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 123 U.K.: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 124 U.K.: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 125 Italy: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 126 Italy: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 127 Italy: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 128 Italy: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 129 Italy: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 130 Italy: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 131 Italy: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 132 Italy: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 133 Italy: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 134 Italy: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 135 Italy: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 136 Spain: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 137 Spain: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 138 Spain: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 139 Spain: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 140 Spain: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 141 Spain: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 142 Spain: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 143 Spain: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 144 Spain: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 145 Spain: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 146 Spain: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 147 Switzerland: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 148 Switzerland: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 149 Switzerland: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 150 Switzerland: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 151 Switzerland: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 152 Switzerland: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 153 Switzerland: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 154 Switzerland: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 155 Switzerland: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 156 Switzerland: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 157 Switzerland: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 158 Ireland: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 159 Ireland: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 160 Ireland: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 161 Ireland: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 162 Ireland: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 163 Ireland: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 164 Ireland: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 165 Ireland: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 166 Ireland: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 167 Ireland: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 168 Ireland: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 169 Denmark: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 170 Denmark: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 171 Denmark: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 172 Denmark: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 173 Denmark: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 174 Denmark: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 175 Denmark: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 176 Denmark: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 177 Denmark: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 178 Denmark: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 179 Denmark: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 180 Belgium: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 181 Belgium: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 182 Belgium: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 183 Belgium: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 184 Belgium: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 185 Belgium: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 186 Belgium: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 187 Belgium: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 188 Belgium: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 189 Belgium: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 190 Belgium: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 191 Rest of Europe: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 192 Rest of Europe: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 193 Rest of Europe: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 194 Rest of Europe: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 195 Rest of Europe: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 196 Rest of Europe: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 197 Rest of Europe: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 198 Rest of Europe: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 199 Rest of Europe: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 200 Rest of Europe: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 201 Rest of Europe: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 202 Asia-Pacific: Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 203 Asia-Pacific: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 204 Asia-Pacific: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 205 Asia-Pacific: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 206 Asia-Pacific: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 207 Asia-Pacific: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 208 Asia-Pacific: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 209 Asia-Pacific: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 210 Asia-Pacific: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 211 Asia-Pacific: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 212 Asia-Pacific: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 213 Asia-Pacific: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 214 Japan: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 215 Japan: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 216 Japan: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 217 Japan: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 218 Japan: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 219 Japan: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 220 Japan: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 221 Japan: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 222 Japan: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 223 Japan: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 224 Japan: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 225 China: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 226 China: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 227 China: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 228 China: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 229 China: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 230 China: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 231 China: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 232 China: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 233 China: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 234 China: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 235 China: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 236 India: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 237 India: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 238 India: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 239 India: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 240 India: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 241 India: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 242 India: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 243 India: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 244 India: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 245 India: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 246 India: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 247 South Korea: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 248 South Korea: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 249 South Korea: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 250 South Korea: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 251 South Korea: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 252 South Korea: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 253 South Korea: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 254 South Korea: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 255 South Korea: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 256 South Korea: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 257 South Korea: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 258 Rest of Asia-Pacific: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 259 Rest of Asia-Pacific: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 260 Rest of Asia-Pacific: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 261 Rest of Asia-Pacific: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 262 Rest of Asia-Pacific: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 263 Rest of Asia-Pacific: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 264 Rest of Asia-Pacific: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 265 Rest of Asia-Pacific: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 266 Rest of Asia-Pacific: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 267 Rest of Asia-Pacific: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 268 Rest of Asia-Pacific: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 269 Latin America: Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 270 Latin America: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 271 Latin America: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 272 Latin America: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 273 Latin America: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 274 Latin America: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 275 Latin America: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 276 Latin America: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 277 Latin America: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 278 Latin America: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 279 Latin America: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 280 Latin America: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 281 Brazil: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 282 Brazil: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 283 Brazil: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 284 Brazil: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 285 Brazil: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 286 Brazil: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 287 Brazil: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 288 Brazil: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 289 Brazil: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 290 Brazil: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 291 Brazil: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 292 Mexico: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 293 Mexico: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 294 Mexico: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 295 Mexico: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 296 Mexico: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 297 Mexico: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 298 Mexico: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 299 Mexico: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 300 Mexico: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 301 Mexico: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 302 Mexico: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 303 Rest of Latin America: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 304 Rest of Latin America: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 305 Rest of Latin America: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 306 Rest of Latin America: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 307 Rest of Latin America: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 308 Rest of Latin America: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 309 Rest of Latin America: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 310 Rest of Latin America: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 311 Rest of Latin America: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 312 Rest of Latin America: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 313 Rest of Latin America: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 314 Middle East & Africa: Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 315 Middle East & Africa: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 316 Middle East & Africa: Photobioreactors Market, by Type, 2022–2031 (USD Million)
Table 317 Middle East & Africa: Bioreactors Market, by Bioprocess, 2022–2031 (USD Million)
Table 318 Middle East & Africa: Bioreactors Market, by Cell Type, 2022–2031 (USD Million)
Table 319 Middle East & Africa: Bioreactors Market, by Usability, 2022–2031 (USD Million)
Table 320 Middle East & Africa: Reusable Bioreactors Market, by Material, 2022–2031 (USD Million)
Table 321 Middle East & Africa: Bioreactors Market, by Scale, 2022–2031 (USD Million)
Table 322 Middle East & Africa: Industrial Scale Bioreactors Market, by Capacity, 2022–2031 (USD Million)
Table 323 Middle East & Africa: Bioreactors Market, by Application, 2022–2031 (USD Million)
Table 324 Middle East & Africa: Bioreactors Market for Commercial Production, by Application, 2022–2031 (USD Million)
Table 325 Middle East & Africa: Bioreactors Market, by End User, 2022–2031 (USD Million)
Table 326 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global Bioreactors Market, by Type, 2024 VS. 2031 (USD Million)
Figure 8 Global Bioreactors Market, by Bioprocess, 2024 VS. 2031 (USD Million)
Figure 9 Global Bioreactors Market, by Cell Type, 2024 VS. 2031 (USD Million)
Figure 10 Global Bioreactors Market, by Usability, 2024 VS. 2031 (USD Million)
Figure 11 Global Bioreactors Market, by Scale, 2024 VS. 2031 (USD Million)
Figure 12 Global Bioreactors Market, by Application, 2024 VS. 2031 (USD Million)
Figure 13 Global Bioreactors Market, by End User, 2024 VS. 2031 (USD Million)
Figure 14 Global Bioreactors Market, by Geography
Figure 15 Global Bioreactors Market, by Product, 2024 VS. 2031 (USD Million)
Figure 16 Global Bioreactors Market, by Bioprocess, 2024 VS. 2031 (USD Million)
Figure 17 Global Bioreactors Market, by Cell Type, 2024 VS. 2031 (USD Million)
Figure 18 Global Bioreactors Market, by Usability, 2024 VS. 2031 (USD Million)
Figure 19 Global Bioreactors Market, by Scale, 2024 VS. 2031 (USD Million)
Figure 20 Global Bioreactors Market, by Application, 2024 VS. 2031 (USD Million)
Figure 21 Global Bioreactors Market, by End User, 2024 VS. 2031 (USD Million)
Figure 22 Global Bioreactors Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 23 North America: Bioreactors Market Snapshot
Figure 24 Europe: Bioreactors Market Snapshot
Figure 25 Asia-Pacific: Bioreactors Market Snapshot
Figure 26 Latin America: Bioreactors Market Snapshot
Figure 27 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 28 Global Bioreactors Market: Competitive Benchmarking, by Product
Figure 29 Global Bioreactors Market: Competitive Dashboard
Figure 30 Global Bioreactors Market: Market Share Analysis/Market Ranking (2023)
Figure 31 Thermo Fisher Scientific, Inc.: Financial Overview (2023)
Figure 32 Merck KGaA: Financial Overview (2023)
Figure 33 Eppendorf AG: Financial Overview (2022)
Figure 34 Sartorius AG: Financial Overview (2022)
Figure 35 Danaher Corporation: Financial Overview (2023)
Figure 36 Donaldson Company, Inc.: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Europe Single-use Bioreactors Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jun-2024
Single-use Bioreactors Market - Global Opportunity Analysis and Industry Forecast (2023-2030)
Published Date: May-2023
Cell Culture Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: Dec-2022
3D Cell Culture Market - Global Opportunity Analysis and Industry Forecast (2023-2030)
Published Date: Jul-2023
